March 14, 2025 HPV Vaccine Reduces Actinic Keratoses VAXAK randomized trial demonstrates significant reduction in precancerous skin lesions following standard 9-valent alphapapillomavirus vaccination. Conexiant
May 27, 2021 Study Finds Adjuvant Immunotherapy of Benefit to Patients With Stage IIB/C Melanoma The ASCO Post
April 17, 2023 Single-Agent Pembrolizumab May Benefit Patients With Advanced Desmoplastic Melanoma The ASCO Post
June 23, 2023 SWOG S1512 Trial: Pembrolizumab Achieves High Response Rates in Rare Type of Melanoma The ASCO Post